KY

Ketan Yerneni

Founder of Decoding Bio

New York, New York

Overview 

Ketan Yerneni is a Principal at KdT Ventures in New York, specializing in investing in various sectors including Medical Devices, BioTech, and Health IT. Notable career highlights include co-founding Decoding Bio and holding roles in business development at Rhaeos and SIA, which was later acquired by Integra LifeSciences.

Work Experience 

KV

KdT Ventures

  • Principal

    2020 - Current

    An early-stage venture firm with a focus on the intersection of frontier computational technologies and science.

KdT Ventures is an early-stage venture capital firm that invests in startups in the data, engineering, and biology sector.

kdtvc.com
DB

Decoding Bio

  • Co-Founder

    2022

    www.decodingbio.com

Decoding Bio mission is to translate technical developments and trends into an easy-to-read format.

decodingbio.com
R

Rhaeos

  • Business Development

    2021 - 2022

    Developing non-invasive diagnostics for patients with hydrocephalus.

Rhaeos is a medical device company that develops wearable sensors to improve the treatment of chronic health conditions.

Raised $19,640,256.00 from National Institutes of Health and Consortium For Technology & Innovation in Pediatrics.

rhaeos.com
S(

SIA (Acquired by Integra LifeSciences)

  • Business Development

    2018 - 2021

    Bettering patient outcomes in reconstructive surgery through clinician-driven innovation.

Surgical Innovation Associates is a developer of implantable polymeric surgical devices for plastic, reconstructive, and general surgery.

Raised $19,325,000.00 from Pioneer Healthcare Partners and THE CATALYTIC IMPACT FOUNDATION (CIF).

sia.health

Education 

Articles About Ketan

Relevant Websites